Non-acute Subdural Hematoma
Conditions
Interventions
Middle Meningeal Artery Embolization with PVA+Atorvastatin:None
Traditional Surgery+Atorvastatin:None
Sponsors
The First Affiliated Hospital of Army Medical University PLA
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years; 2. Non-acute SDH confirmed by cranial imaging (<30% high-dense components); 3. Symptomatic non-acute SDH in need of surgery, including headache, cognitive impairment, ataxia, epilepsy, focal neurological deficit, or decreased consciousness; 4. Patients fully understand the study and voluntarily participate with signed informed consent.
Exclusion criteria
Exclusion criteria: 1. History of surgical or endovascular treatment for the SDH; 2. In need of urgent subdural hematoma evacuation; 3. Non-acute SDH due to vascular malformation, tumor, arachnoid cyst, spontaneous intracranial hypotension or craniotomy; 4. Severe comorbid illness resulting in life expectancy <1 year; 5. Surgical contraindications, including intolerance of surgery due to poor general health, severe coagulation disorder, etc; 6. Pregnancy or breast-feeding; 7. Poor compliance, unable to follow study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate of hematoma; | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in maximum thickness of hematoma;Improvement in functional score (mRS);Incidence of surgical complications;Procedural adverse events;Mortality; | — |
Countries
China
Contacts
Public ContactZhi Chen
The First Affiliated Hospital of Army Medical University PLA
Outcome results
None listed